As filed with the Securities and Exchange Commission on February 3, 2021
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER
THE SECURITIES ACT OF 1933
OBALON THERAPEUTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
Delaware
|
|
26-1828101
|
(State or Other Jurisdiction
|
|
(I.R.S. Employer Identification No.)
|
of Incorporation or Organization)
|
|
|
5421 Avenida Encinas, Suite F Carlsbad, California 92008
(Address of Principal Executive Offices) (Zip Code)
Obalon Therapeutics, Inc. Amended and Restated 2016 Equity Incentive Plan
Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan
(Full Title of the Plan)
Andrew Rasdal
President and Chief Executive Officer
Obalon Therapeutics, Inc.
5421 Avenida Encinas, Suite F
Carlsbad, California 92008
(844) 362-2566
(Name, address, and telephone number, including area code, of agent for service)
Copy to:
B. Shayne Kennedy
LATHAM & WATKINS LLP
650 Town Center Drive, 20th Floor
Costa Mesa, California 92626
Telephone: (714) 540-1235
Facsimile: (714) 755-8290